Roche’s Tarceva approaches EU approval

June 28, 2005
Sales and Marketing

Roche's new oral cancer treatment Tarceva has received a recommendation from the EMEA's advisory committee, paving the way for its …

AstraZeneca’s defeat opens door to more challenges

June 24, 2005
Sales and Marketing

Pharmaceutical companies found guilty of violating European antitrust laws can expect steeper fines than AstraZeneca, according to a leading law …

Side-effect doubts cloud future of Pargluva and Galida

June 24, 2005
Sales and Marketing

A study comparing novel treatment Pargluva with a best-selling diabetes drug has yielded some positive results for the new drug, …

Acomplia filed in Europe and US

June 24, 2005
Sales and Marketing

Sanofi-Aventis has submitted its new obesity treatment Acomplia to the European Union and US regulators.Even before its filing Acomplia (rimonabant) …

Novartis hails new MS pill as a breakthrough

June 23, 2005
Sales and Marketing

Novartis says its new multiple sclerosis  treatment is more effective than existing drugs in delaying the progress of the disease, …

Pfizer buys anti-infective specialists Vicuron

June 17, 2005
Sales and Marketing

Pfizer has paid almost $2 billion for a US biopharmaceutical company with two promising anti-infective drugs.The acquisition of Vicuron Pharmaceuticals …

AZ fined E60 million by European Commission

June 16, 2005
Sales and Marketing

AstraZeneca has been fined E60 million by the European Commission for illegally trying to extend the patent on its ulcer …

Bristol-Myers Squibb to limit direct to consumer advertising

June 15, 2005
Medical Communications

Bristol-Myers Squibb has pledged to observe a stricter code of conduct in the promotion of its products to the public …

Older painkillers linked to heart attack risk

June 14, 2005
Sales and Marketing

Two widely used painkillers ibuprofen and naproxen have been linked to increased rates of heart attacks in patients, a new …

BMS pays out $89 million in court settlement

June 14, 2005
Sales and Marketing

Bristol-Myers Squibb has reached a deal to pay $89 million to settle four lawsuits related to inflated inventories and other …

Hepatitis B market to double by 2010

June 14, 2005
Sales and Marketing

The hepatitis B market will double in size by 2010 and hit sales of $1 billion, according to analysts Datamonitor. …

The devil is in the detail

June 10, 2005

Practice based commissioning looks set to have a major impact on how pharma companies organise their salesforces and promote and …

The Gateway to Local Adoption Series

Latest content